ACV (Virtus Diversified Income & Convertible Fund) Stock Analysis - SEC Filings

Virtus Diversified Income & Convertible Fund (ACV) is a publicly traded Financial Services sector company. As of May 21, 2026, ACV trades at $26.25 with a market cap of $272.27M and a P/E ratio of 0.00. ACV moved +1.37% today. Year to date, ACV is -2.05%; over the trailing twelve months it is +20.15%. Its 52-week range spans $17.00 to $29.04. Analyst consensus is hold with an average price target of $0.00. Rallies surfaces ACV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find ACV SEC filings?

Rallies organizes ACV SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

ACV Key Metrics

Key financial metrics for ACV
MetricValue
Price$26.25
Market Cap$272.27M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.18%
52-Week High$29.04
52-Week Low$17.00
Volume19
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest ACV News

Recent ACV Insider Trades

  • MCDANIEL CONNIE D bought 237 (~$5.19K) on Jun 17, 2025.
  • DeCotis Deborah A bought 191 (~$5.01K) on Mar 3, 2022.
  • WALTON R KEITH bought 375 (~$10.70K) on Feb 1, 2022.

ACV Analyst Consensus

1 analysts cover ACV: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is hold. Average price target: $0.00.

Common questions about ACV

Where can I find ACV SEC filings?
Rallies organizes ACV SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show ACV 10-K and 10-Q filings?
Rallies organizes ACV SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is ACV research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ACV. It does not provide personalized investment advice.
ACV

ACV